510(k) Report

De Novo · Granted

Granted

WallFlex Biliary RX Fully Covered Stent System RMV

DEN150040De NovoGranted Jun 3, 2016280-day reviewClass II21 CFR 876.5011

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific · PNB Biliary Stent System For Benign Strictures

Granted on Jun 3, 2016 as a new device type through De Novo after a 280-day review. 2 later devices descend from it.

Decided
Jun 3, 2016
Review
280 days
Class
Class II
Product code
PNB
Recalls
None

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2024: 2 descendants cleared201620182020202220242026
  1. This deviceDEN150040 WallFlex Biliary RX Fully Covered Stent System RMVBoston Scientific · 2016
  2. Descendant · cites it directly · 1 of its ownK240464 WallFlex Biliary RX Stent System; Epic Biliary Stent System…Boston Scientific · 2024
  3. Descendant · 2 generations on · 0 of its ownK242950 WallFlex Biliary PLUS RX Stent SystemBoston Scientific · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K240464WallFlex Biliary RX Stent System; Epic Biliary Stent System; WallFlex Biliary RX Fully…Boston Scientific · 2024 · cites it directly1descendant
  • K242950WallFlex Biliary PLUS RX Stent SystemBoston Scientific · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN150040WallFlex Biliary RX Fully Covered Stent System RMVBoston Scientific2016—
+1K240464WallFlex Biliary RX Stent System; Epic Biliary Stent System; WallFlex Biliary…Boston Scientific2024—
+2K242950WallFlex Biliary PLUS RX Stent SystemBoston Scientific2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202420
FIG. 1 — Lineage of DEN150040, 2016–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PNB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K240464WallFlex Biliary RX Stent System; Epic Biliary Stent System; WallFlex Biliary RX Fully…Boston Scientific20241

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K240464 (Boston Scientific, 2024) has gone furthest, with 1 descendant of its own.

How does its category compare?

All PNB devices

PNB Biliary Stent System For Benign Strictures: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · PNB

1in 2016

2016: 1
2007high 1 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PNB

Too few PNB 510(k)s in any year since 2007 to give a median.

Recalls per year · PNB

No recall names PNB since 2007.

Adverse event reports per year · PNB

36in 2025

2016: 12017: 222018: 482019: 462020: 482021: 292022: 162023: 272024: 392025: 36
2007high 48 (2018) · low 0 (2007)2025

MAUDE reports naming product code PNB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20161—01
20170—022
20180—048
20190—046
20200—048
20210—029
20220—016
20230—027
20240—039
20250—036
20260—0—

What is it indicated for?

indicated for indwell up to 12 months in the treatment of benign biliary strictures secondary to chronic pancreatitis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN150040: WallFlex Biliary RX Fully Covered Stent System RMV.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/DEN150040

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026